|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 401/14 | (2006.01) |
| C07D 403/04 | (2006.01) | ||
| C07D 403/14 | (2006.01) | ||
| C07D 487/04 | (2006.01) | ||
| A61K 31/53 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Patento numeris | 3072890 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14168117.1 |
| Europos patento paraiškos padavimo data | 2010-07-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-09-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-10-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 223684 P | 2009-07-07 | US | |
| 247448 P | 2009-09-30 | US | |
| 318195 P | 2010-03-26 | US |
| (72) |
REWCASTLE, Gordon Wiliam, NZ
TSANG, Kit, Yee, NZ
GAMAGE, Swarnalatha, Akuratiya, NZ
GIDDENS, Anna, Claire, NZ
|
| (73) |
MEI Pharma, Inc.,
3611 Valley Centre Drive, Suite 500, San Diego, CA 92130,
US
|
| (54) | Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy |
| Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy |